Steven Cohen Rhythm Pharmaceuticals, Inc. Transaction History

Point72 Asset Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$15.81 - $27.8 $65,548 - $115,258	4,146 New	4,146 $95,000
Q1 2023 May 15, 2023	BUY	$16.88 - $34.24 $201,800 - $409,339	11,955 New	11,955 $213,000
Q2 2018 Aug 14, 2018	SELL	$17.02 - $35.2 $3.06 Million - $6.34 Million	-180,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$19.9 - $32.25 $1.99 Million - $3.23 Million	100,000 Added 125.0%	180,000 $3.58 Million
Q4 2017 Feb 14, 2018	BUY	$22.0 - $30.51 $1.76 Million - $2.44 Million	80,000	80,000 $2.33 Million

178

69.1M

467K

224K

Ticker RYTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,720,000
Market Cap $2.86B
Description
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.